Alan Heldman

Alan W. Heldman (born 1962) is an American interventional cardiologist. Heldman graduated from Harvard College, University of Alabama School of Medicine, and completed residency and fellowship training at Johns Hopkins University School of Medicine. He held positions on the faculty of Johns Hopkins from 1995 to 2007. In 2007 he became Clinical Chief of Cardiology at the University of Miami, Leonard M. Miller School of Medicine.

He published one of the first studies showing that a drug-coated stent (now known as a drug-eluting stent) could prevent restenosis.^[1] His research interests include delivery of stem cells^[2] to the heart for repair of myocardial infarction.^[3] He is the principal investigator for a Phase I-II clinical trial of stem cell therapy for patients with left ventricular dysfunction after myocardial infarction.

His clinical interests include high risk and complex coronary intervention, treatment of hypertrophic cardiomyopathy, including with alcohol septal ablation,^[4] non-surgical treatments for valvular and structural heart disease, and strategies to eliminate complications from interventional cardiology procedures.

He was engaged to Chinese-Malaysian actress Michelle Yeoh.

References

^ Heldman, AW; Cheng, L; Jenkins, GM; Heller, PF; Kim, DW; Ware Jr, M; Nater, C; Hruban, RH; Rezai, B (2001). "Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis". Circulation. 103 (18): 2289–95. doi:10.1161/01.CIR.103.18.2289. PMID 11342479. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
^ Heldman, AW; Hare, JM (2008). "Cell therapy for myocardial infarction: Special delivery". Journal of Molecular and Cellular Cardiology. 44 (3): 473–6. doi:10.1016/j.yjmcc.2007.10.024. PMC 2754212. PMID 18234211.
^ Amado, LC; Saliaris, AP; Schuleri, KH; St John, M; Xie, JS; Cattaneo, S; Durand, DJ; Fitton, T; Kuang, JQ (2005). "Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction". Proceedings of the National Academy of Sciences of the United States of America. 102 (32): 11474–9. doi:10.1073/pnas.0504388102. PMC 1183573. PMID 16061805. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
^ Heldman, AW; Wu, KC; Abraham, TP; Cameron, DE (2007). "Myectomy or alcohol septal ablation surgery and percutaneous intervention go another round". Journal of the American College of Cardiology. 49 (3): 358–60. doi:10.1016/j.jacc.2006.10.029. PMID 17239718.

External links

[1] Heldman, AW; Cheng, L; Jenkins, GM; Heller, PF; Kim, DW; Ware Jr, M; Nater, C; Hruban, RH; Rezai, B (2001). "Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis". Circulation. 103 (18): 2289–95. doi:10.1161/01.CIR.103.18.2289. PMID 11342479. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)

[2] Heldman, AW; Hare, JM (2008). "Cell therapy for myocardial infarction: Special delivery". Journal of Molecular and Cellular Cardiology. 44 (3): 473–6. doi:10.1016/j.yjmcc.2007.10.024. PMC 2754212. PMID 18234211.

[3] Amado, LC; Saliaris, AP; Schuleri, KH; St John, M; Xie, JS; Cattaneo, S; Durand, DJ; Fitton, T; Kuang, JQ (2005). "Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction". Proceedings of the National Academy of Sciences of the United States of America. 102 (32): 11474–9. doi:10.1073/pnas.0504388102. PMC 1183573. PMID 16061805. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)

[4] Heldman, AW; Wu, KC; Abraham, TP; Cameron, DE (2007). "Myectomy or alcohol septal ablation surgery and percutaneous intervention go another round". Journal of the American College of Cardiology. 49 (3): 358–60. doi:10.1016/j.jacc.2006.10.029. PMID 17239718.

[1]

[2]

[3]

[4]